Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2025 04:13 ET | Source: Research and Markets

Hidradenitis Suppurativa Market Analysis and Forecast, 2025-2035 - Emerging Biotech Innovations Offer New Hope for Hidradenitis Suppurativa Patients

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Hidradenitis Suppurativa Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has...
May 03, 2024 06:39 ET | Source: Research and Markets

Hidradenitis Suppurativa Pipeline Analysis Report 2024: Featuring 24+ Companies and 24+ Pipeline Drugs Including Vilobelimab (InflaRx), Secukinumab (Novartis), Avacopan (Chemo Centryx), Imsidolimab (AnaptysBio)

Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Hidradenitis Suppurativa - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
April 25, 2023 06:13 ET | Source: Research and Markets

Hidradenitis Suppurativa (HS) - Market Insight, Epidemiology And Market Forecast - 2032

Dublin, April 25, 2023 (GLOBE NEWSWIRE) -- The "Hidradenitis Suppurativa (HS) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...
April 13, 2023 06:23 ET | Source: Research and Markets

Global Hidradenitis Suppurativa Market Forecast to 2030: Increasing Smoking Rates Drives Growth

Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Global Hidradenitis Suppurativa Market: Analysis By Patients, By Drugs (Povorcitinib, Bimekizumab, Sonelokimab), By Region Size (The US, Europe, Rest...